However, recent evidence suggests that a variable proportion of EpCAM-negative BC cells can also be detected in the peripheral blood of patients, in relation to the expression of EMT markers, thus providing more information for metastatic evolution and management of the disease12–15,21,41. The gene discussed is EPCAM; the disease is breast cancer.